Our compiler is Compaq Visual Fortran
(latest version).
We appreciate your thoughts on that.
__
Joachim GREVEL, Ph.D.
MERCK SERONO International S.A.
Exploratory Medicine
1202 Geneva
Tel: +41.22.414.4751
Fax: +41.22.414.3059
Email: [EMAIL PROTEC
We run NONMEM VI without the recent bug fixes in a "naked" fashion on the
server, and with "wings" on the PCs. Our compiler is Compaq Visual Fortran
(latest version).
We appreciate your thoughts on that.
__________
Joachim GREVEL, Ph.D.
MERCK S
with "wings" on the PCs. Our compiler is Compaq Visual Fortran
(latest version).
We appreciate your thoughts on that.
__
Joachim GREVEL, Ph.D.
MERCK SERONO International S.A.
Exploratory Medicine
1202 Geneva
Tel: +41.22.414.4751
Fax: +41.22.41
ith "wings" on the PCs. Our compiler is Compaq Visual Fortran
(latest version).
We appreciate your thoughts on that.
__________
Joachim GREVEL, Ph.D.
MERCK SERONO International S.A.
Exploratory Medicine
1202 Geneva
Tel: +41.22.414.4751
Fax: +41.22.41
.
Joachim
__
Joachim GREVEL, Ph.D.
MERCK SERONO International S.A.
Exploratory Medicine
1202 Geneva
Tel: +41.22.414.4751
Fax: +41.22.414.3059
Email: [EMAIL PROTECTED]
Paul wrote:
I have data from PO, IP, and SQ(pump) infusions of this compound that I am
x27;t we write Phase I (dose escalation) protocols
for just about all new drugs (not only anticancer drugs) with doses based
on the size of the volunteers (patients)? What do my colleagues from
industry and the regulatory agencies think?
Joachim
__
Jo
production phase.
Any other users out there who are happy with gfortran as substitute for
g77 as compiler?
Joachim
__
Joachim GREVEL, Ph.D.
Modeling and Simulation
MERCK SERONO International S.A.
Exploratory Medicine
1202 Geneva
Tel: +41.22.414.4751
Fax
allometrically scale a first-order rate constant of
absorption after oral dosing?
b) how do we allometrically scale a first-order rate constant of
absorption from a subcutaneous injection site?
Thank you for your thoughts,
Joachim
__
Joachim GREVEL, Ph.D.
MERCK
with a grid engine.
7. It all takes more time than you think: make generous budgets and
time lines.
I hope I helped more than I confused,
Joachim
__
Joachim GREVEL, Ph.D.
MERCK SERONO International S.A.
Exploratory Medicine
1202 Geneva
Tel:
system administrator and modeler at the same time.
Joachim
__
Joachim GREVEL, Ph.D.
MERCK SERONO International S.A.
Exploratory Medicine
1202 Geneva
Tel: +41.22.414.4751
Fax: +41.22.414.3059
Email: [EMAIL PROTECTED]
"A.J. Rossini" <[EMAIL PR
him
__
Joachim GREVEL, Ph.D.
MERCK SERONO International S.A.
Exploratory Medicine
1202 Geneva
Tel: +41.22.414.4751
Fax: +41.22.414.3059
Email: [EMAIL PROTECTED]
"Jun Shen" <[EMAIL PROTECTED]>
10/22/2008 04:08 PM
To
[EMAIL PROTECTED]
cc
nmusers@globom
mers, review of modeling
results and conclusions, continued education (which involves also this
user network). Indeed, the NONMEM user network is listed in our risk
analysis as a means to mitigate.
Thank you for your continued interest,
Joachim
______
Joachim GREV
, the discussions on our usernet are extremely relevant
to our daily modeling work.
Cheers to our usernet!
Joachim
__
Joachim GREVEL, Ph.D.
MERCK SERONO International S.A.
Exploratory Medicine
1202 Geneva
Tel: +41.22.414.4751
Fax: +41.22.414.3059
Email: [EMAIL PROT
fies only one
population.
Good luck,
Joachim
______
Joachim GREVEL, Ph.D.
Merck Serono S.A. - Genève
Human Pharmacology
1202 Geneva
Tel: +41.22.414.4751
Fax: +41.22.414.3059
Email: joachim.gre...@merckserono.net
nidal.alhun...@gmail.com
Sent by: owner-nmus...@g
(ETA(1))
Joachim
__
Joachim GREVEL, Ph.D.
Merck Serono S.A. - Genève
Human Pharmacology
1202 Geneva
Tel: +41.22.414.4751
Fax: +41.22.414.3059
Email: joachim.gre...@merckserono.net
"Huali Wu"
03/13/2009 03:56 PM
To
,
cc
Subject
Re: [NMuse
us about your findings,
Joachim
__________
Joachim GREVEL, Ph.D.
Merck Serono S.A. - Genève
Human Pharmacology
1202 Geneva
Tel: +41.22.414.4751
Fax: +41.22.414.3059
Email: joachim.gre...@merckserono.net
joachim.gre...@merckserono.net
Sent by: owner-nmus...@globomaxnm.com
03/13/2009 08:23 AM
To
n
pointing that out in his workshop.
Joachim
__
Joachim GREVEL, Ph.D.
Merck Serono S.A. - Genève
Human Pharmacology
1202 Geneva
Tel: +41.22.414.4751
Fax: +41.22.414.3059
Email: joachim.gre...@merckserono.net
Leonid Gibiansky
Sent by: owner-nmus
Hi Pavel,
Please, look up an oldtimer with decades of experience: www.bastinc.eu
Would be happy to do business with you,
Joachim
Joachim Grevel, PhD
Scientific Director
BAST Inc Limited
BioCity Nottingham
Pennyfoot Street
Nottingham, NG1 1GF
Tel: +44 (0)115 8120497
Dear Dirk,
If your full model has 4 parameters more than your reduced model, and you
estimate all four of them, it does not matter how many observations
contribute to each of them. Thus you should evaluate Diff_OFV at 4 degrees
of freedom.
Happy modelling,
Joachim
Joachim Grevel
ulated data files with R or SAS and
report the distribution of the Cmin and Tmin you found.
Please, come back with more questions in case I have confused you,
Joachim
Joachim Grevel, PhD
Scientific Director
BAST Inc Limited
BioCity Nottingham
Pennyfoot Street
Nottingham, NG1 1GF
Tel:
these
predictions in the output table and play with them as you like.
Hope this helps you furher,
Joachim
From: Friederike Kanefendt [mailto:friederike.kanefe...@uni-bonn.de]
Sent: 06 April 2011 14:05
To: Joachim Grevel; nmusers@globomaxnm.com
Subject: AW: [NMusers] Modeling Cmin
easing NSIG
and SIGL
I have not checked your code in detail, but this would be my first choice
for improvement.
Good luck!
Joachim
Joachim Grevel, PhD
Scientific Director
BAST Inc Limited
BioCity Nottingham
Pennyfoot Street
Nottingham, NG1 1GF
Tel: +44 (0)115 8120497
an end.
What's required is "Fingerspitzengefuehl" (sorry, my Anglophone friends)
Joachim
-Original Message-
From: owner-nmus...@globomaxnm.com [mailto:owner-nmus...@globomaxnm.com] On
Behalf Of Friederike Kanefendt
Sent: 15 August 2011 13:13
To: Nick Holford; Joachim
Windows in the
installation guide to NONMEM.
Good Luck,
Joachim
Joachim Grevel, PhD
Scientific Director
BAST Inc Limited
BioCity Nottingham
Pennyfoot Street
Nottingham, NG1 1GF
Tel: +44 (0)115 8120497
From: owner-nmus...@globomaxnm.com [mailto:owner-nmus...@globomaxnm.com] On
Dear Svetlana,
A good starting point would be the "NONMEM Users Guide Introduction to
NONMEM 7.2.0" chapter I.24 p40ff plus examples. Not sure what you call
"Bayesian networks".
Good Luck,
Joachim
-Original Message-
From: owner-nmus...@globomaxnm.com [mailto:owner-nmus...@globomaxnm.com
Wishart matrix in
his historic contributions to NMusers, but again I could not find out how to
obtain it. If it does not happen in NONMEM, is there a tool in R that can
give me that matrix?
Your help is greatly appreciated,
Joachim
Joachim Grevel, PhD
Scientific Director
BAST Inc Limited
use NWPRI (i.e. with the inverse wishart for OMEGA's), or TNPRI, which uses
a multivariate normal for the OMEGA's. Do you have any idea when to use
either of these two possible implementations ?
Thanks,
Coen
>>> "Joachim Grevel" 02/22/12 2:11 PM >>>
Dea
1:09 PM
To: Mats Karlsson; 'Joachim Grevel'; 'Coen van Hasselt'; 'nmusers'
Subject: RE: [NMusers] OMEGA priors using modes of inverse Wishart matrix
Hi
An appropriate value for dof of the IW is difficult to determine. While it
can be set at n-1 from a prior this is som
instruction and use simply the covariance matrix
of the previous NONMEM analysis of the large data file:
$OMEGA BLOCK(2)
0.000131 FIX
0.191 0.000627
$THETA (138 FIX)
There is not really a big difference in my example.
Joachim
Joachim Grevel, PhD
Scientific Director
BAST
drug (CVVH - what is that?), but it may be sufficient to obtain
individual predictions (to relate dialysis flow rate to individual clearance
estimates?).
The technicalities of setting up informative priors have been discussed in
this forum recently.
Good luck,
Joachim
Joachim Grevel, PhD
did a bootstrap.
Good luck,
Joachim
Joachim Grevel, PhD
Scientific Director
BAST Inc Limited
Loughborough Innovation Centre
Charnwood Building
Holywell Park, Ashby Road
Loughborough, LE11 3AQ
Tel: +44 (0)1509 222908
Confidentiality Notice: This message is private and may
://www.mail-archive.com/nmusers@globomaxnm.com/
On Sat, Jan 26, 2013, at 07:52 AM, Joachim Grevel wrote:
http://www.cognigencorp.com/index.php/cognigen/resources_nonmem
Dear NONMEM users,
For several months now I cannot search the NONMEM usersnet archive. Can
somebody please tell me where
no
Send CV to Joachim Grevel (jgre...@bastinc.eu)
More informationwww.bastinc.eu
Joachim Grevel, PhD
Scientific Director
BAST Inc Limited
Loughborough Innovation Centre
Charnwood Building
Holywell Park, Ashby Road
Loughborough, LE11 3AQ
Tel
test our
successive prototypes for free:
http://www.bastinc.eu/component/smartformer/?formid=8
We are looking forward to working with you.
Kind regards,
Joachim
Joachim Grevel, PhD
Scientific Director
BAST Inc Limited
Loughborough Innovation Centre
Charnwood Building
Holywell
Midlands, England,
UK
Work from home no
Send CV to Joachim Grevel (
<mailto:jgre...@bastinc.eu> jgre...@bastinc.eu)
More information <http://www.bastinc.eu> www.bastinc.eu
Joachim Grevel, PhD
Scientific Director
BAST Inc Limited
best,
Joachim
Joachim Grevel, PhD
Scientific Director
BAST Inc Limited
Loughborough Innovation Centre
Charnwood Building
Holywell Park, Ashby Road
Loughborough, LE11 3AQ
Tel: +44 (0)1509 222908
Dear Leonid and Bernard,
Why not treat hair like a urine compartment that is not emptied until the hair
is pulled out with the root? NONMEM user guides contain all you need to model a
"collection compartment" like urine/hair.
Have fun,
Joachim
Joachim Grevel, PhD
Scientific Directo
opinions.
Good luck,
Joachim
Joachim Grevel, PhD
Scientific Director
BAST Inc Limited
Science & Enterprise Park
Loughborough University
Loughborough, LE11 3AQ
United Kingdom
Tel: +44 (0)1509 222908
www.bastinc.eu <http://www.bastinc.eu/>
From:
been to ASCO either.
Good luck,
Joachim
Joachim Grevel, PhD
Scientific Director
BAST Inc Limited
Science & Enterprise Park
Loughborough University
Loughborough, LE11 3AQ
United Kingdom
Tel: +44 (0)1509 222908
www.bastinc.eu <http://www.bastinc.eu/>
From:
39 matches
Mail list logo